DrugPatentWatch Database Preview
TEMOVATE E Drug Profile
see a sample report or, see our see our flat-rate plans
When do Temovate E patents expire, and what generic alternatives are available?
The generic ingredient in TEMOVATE E is clobetasol propionate. There are thirteen drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.
Summary for TEMOVATE E
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: | 56 |
| Clinical Trials: | 2 |
| Patent Applications: | 4,305 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | TEMOVATE E at DailyMed |
Medical Subject Heading (MeSH) Categories for TEMOVATE E
Synonyms for TEMOVATE E
| (11b,16b)-21-Chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione |
| (1R,2S,10S,11S,13S,14R,15S,17S)-14-(2-CHLOROACETYL)-1-FLUORO-17-HYDROXY-2,13,15-TRIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-14-YL PROPANOATE |
| [(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate |
| 122C467 |
| 21-chloro-9-fluoro-11 beta-hydroxy-16 beta-methylpregna-1,4-diene-3,20-dione 17-propionate |
| 21-Chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione (11beta,16beta)- |
| 21-Chloro-9-fluoro-11b,17-dihydroxy-16b-methylpregna-1,4-diene-3,20-dione 17-propionate |
| 21-chloro-9-fluoro-11beta-hydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl propanoate |
| 21-Chloro-9-fluoro-11beta-hydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate |
| 21-Chloro-9-fluoro-11beta,17-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate |
| 21-Chloro-9alpha-fluoro-11beta,17alpha-dihydroxy-16beta-methyl-1,4-pregnadiene-3,20-dione 17-Propionate |
| 25122-46-7 |
| 779619577M |
| AB00383081_11 |
| AB00383081-10 |
| AB1009262 |
| AC-17990 |
| AC1L1OG9 |
| AC1Q3T8C |
| AKOS015951278 |
| Ambap25122-46-7 |
| AMOT0927 |
| AN-14318 |
| AS-12555 |
| BCP0726000094 |
| BCP9000539 |
| BDBM39347 |
| BRD-K10799896-001-10-6 |
| Butavate |
| C-22667 |
| C25H32ClFO5 |
| CAS-25122-46-7 |
| CC-25914 |
| CCG-220781 |
| CCI 4725 |
| CCI-4725 |
| CGP 9555 |
| CHEBI:31414 |
| CHEMBL1159650 |
| cid_32798 |
| Clarelux |
| Clobesol |
| Clobestasol propionate |
| clobetasol 17-propanoate |
| Clobetasol 17-propionate |
| Clobetasol for peak identification, European Pharmacopoeia (EP) Reference Standard |
| CLOBETASOL PROPIONATE |
| CLOBETASOL PROPIONATE (EMOLLIENT) |
| Clobetasol propionate (JP17/USP) |
| Clobetasol propionate [USAN:JAN] |
| Clobetasol propionate [USAN:USP:JAN] |
| Clobetasol propionate E |
| Clobetasol propionate gel |
| Clobetasol propionate, analytical standard |
| Clobetasol propionate, European Pharmacopoeia (EP) Reference Standard |
| Clobetasol Propionate, Pharmaceutical Secondary Standard; Certified Reference Material |
| Clobetasol propionate, United States Pharmacopeia (USP) Reference Standard |
| Clobetasole propionate |
| Clobetasolpropionat mikron. |
| Clobetasolpropionate |
| Clobex |
| Cormax |
| Cormax (TN) |
| CPD000058745 |
| CS-2594 |
| D01272 |
| DB01013 |
| Dermoval |
| Dermovate |
| Dermoxinale |
| DSSTox_CID_25907 |
| DSSTox_GSID_45907 |
| DSSTox_RID_81219 |
| DTXSID6045907 |
| EBD6220 |
| EINECS 246-634-3 |
| Embeline |
| Embeline E |
| GR 2/925 |
| GTPL7062 |
| HMS2090A04 |
| HMS2230H08 |
| HMS3259A10 |
| HY-13600 |
| Impoyz |
| LS-118433 |
| MFCD00058499 |
| MLS000028708 |
| MLS001076345 |
| NC00551 |
| NCGC00023373-03 |
| NCGC00023373-04 |
| NCGC00095078-01 |
| Olux |
| Olux E |
| OLUX FOAM |
| Olux-E |
| Opera_ID_1470 |
| PL000420 |
| Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11-beta,17-dihydroxy-16-beta-methyl-, 17-propionate |
| Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11-beta,17-dihydroxy-16-beta-methyl-,17-propionate |
| Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11-hydroxy- 16-methyl-17-(1-oxopropoxy)-, (11ss,16ss)- |
| Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (11beta,16beta)- |
| Propionic acid clobetasol |
| s2584 |
| SCHEMBL3997 |
| SMR000058745 |
| SR-01000000280 |
| SR-01000000280-4 |
| Temovate |
| Tox21_111414 |
| Tox21_111414_1 |
| UNII-779619577M |
| Yugofin |
| ZINC3977767 |
US Patents and Regulatory Information for TEMOVATE E
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fougera Pharms | TEMOVATE E | clobetasol propionate | CREAM;TOPICAL | 020340-001 | Jun 17, 1994 | DISCN | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
